Simpson Thacher Represents Underwriters in HK$337.57 Million Hong Kong IPO and Rule 144A/Regulation S Offering of MicroPort NeuroTech
07.15.22
This is only gets display when printing
Simpson Thacher represented the underwriters in the initial public offering and Rule 144A and Regulation S offering by MicroPort NeuroTech Limited (“MicroPort NeuroTech”) (HKEX: 2172). MicroPort NeuroTech offered 13,700,000 shares in its global offering prior to the exercise of the underwriters’ overallotment option. The base offering size is HK$337.57 million (approximately US$43.28 million). The shares of MicroPort NeuroTech are listed on the Hong Kong Stock Exchange. J.P. Morgan and CICC acted as joint sponsors, joint global coordinators, joint bookrunners and joint lead managers.
MicroPort NeuroTech is a China-based company in the neuro-interventional medical device industry, dedicated to providing innovative solutions for physicians and patients.
The Simpson Thacher team for the transaction included Christopher Wong, Yi Gao, Michelle Leung, Emily Yiu, Cherrie Zhang, Vincy Huang and Zhengyuan Fan (Capital Markets).